What Aquestive Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 16 |
| Total trades | 10 | 44 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 169,602 | 1,261,602 |
| Disposed | 86,464 | 1,341,798 |
| Net activity | +83,138 | −80,196 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cochran John | Director | Oct 21 | Other Transaction · J | +62,229 | — | — | 161,715 |
| Barber Daniel | President and CEO | Oct 15 | Open-market sale · S | −25,000 | $4.22 | −$106K | 627,317 |
| Barber Daniel | President and CEO | Sep 15 | Open-market sale · S | −25,000 | $4.82 | −$120K | 652,317 |
| Korczynski Sherry | Chief Commercial Officer | Sep 09 | Open-market sale · S | −8,750 | $5.22 | −$45.7K | 235,689 |
| Korczynski Sherry | Chief Commercial Officer | Sep 09 | Exercise / conversion · M | +8,750 | $2.65 | +$23.2K | 244,439 |
| Boyd Peter E. | Chief People Officer | Sep 09 | In/At-money Exercise · X | +2,293 | $0.96 | +$2.2K | 284,024 |
| Barber Daniel | President and CEO | Sep 08 | In/At-money Exercise · X | +91,743 | $0.96 | +$88.1K | 677,317 |
| Jung Cassie | Chief Operating Officer | Sep 03 | In/At-money Exercise · X | +4,587 | $0.96 | +$4.4K | 206,833 |
| Barber Daniel | President and CEO | Aug 17 | Open-market sale · S | −25,000 | $4.29 | −$107K | 585,574 |
| Korczynski Sherry | Chief Commercial Officer | Aug 14 | Withheld — tax / exercise cost · F | −2,714 | $4.25 | −$11.5K | 235,689 |
| Barber Daniel | President and CEO | Jul 16 | Open-market sale · S | −20,369 | $4.00 | −$81.5K | 610,574 |
| Barber Daniel | President and CEO | Jul 15 | Open-market sale · S | −4,631 | $4.03 | −$18.7K | 630,943 |
| Krop Julie | Director | Jun 23 | Open-market sale · S | −25,000 | $5.02 | −$125K | 0 |
| Krop Julie | Director | Jun 23 | Exercise / conversion · M | +25,000 | $0.71 | +$17.8K | 25,000 |
| Barber Daniel | President and CEO | Jun 15 | Open-market sale · S | −25,000 | $4.16 | −$104K | 635,574 |
| Korczynski Sherry | Chief Commercial Officer | Jun 08 | Withheld — tax / exercise cost · F | −2,714 | — | — | 238,403 |
| Zalewski Thomas A. | Chief Legal Officer | May 18 | Grant / award · A | +100,000 | — | — | 100,000 |
| Barber Daniel | President and CEO | May 15 | Open-market sale · S | −8,257 | $4.29 | −$35.4K | 660,574 |
| Cioffi Melina | SVP, Regulatory Affairs | May 15 | Withheld — tax / exercise cost · F | −1,667 | $4.17 | −$6.95K | 273,200 |
| Braender Lori J | Corporate Secretary | May 07 | Withheld — tax / exercise cost · F | −135,690 | $4.23 | −$574K | 231,042 |
Loading...
